chronic pain

Releviate Therapeutics Inks Exclusive License for Human Monoclonal Antibodies for Chronic Pain Indications

Releviate™ Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, signs an exclusive license for two patent pending human monoclonal antibodies developed by researchers at the University of California, Riverside and [...]

Research That Could Be a Chronic Pain Game-Changer

AAPM member Paul Glare, MD, discusses the work of the multidisciplinary unit at Pain Management Research Institute (PMRI), University of Sydney, Australia, that focuses on the medical, psychological, and philosophical aspects of pain. Read more.

AAPM is dedicated to advancing multidisciplinary pain care, education, advocacy, and research to improve the quality of life for our members and those they treat.

AAPM

Resources

Contact

10440 Little Patuxent Pkwy,
Ste. 300
Columbia, MD 21044

P: (800) 917-1619 Ext. 102
F: (407) 749-0714

Join Now

© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources | Powered by Insight Marketing Group
American Academy of Pain (AAMP) is a nonprofit, 501(c)(6) tax-exempt organization.